| 查看: 65 | 回复: 0 | ||
| 当前主题已经存档。 | ||
[资源]
JASN-CKD患者代谢性骨病的发病机理及治疗策略
|
||
|
Metabolic Bone Disease in Chronic Kidney Disease Kevin J. Martin and Esther A. González Division of Nephrology, Saint Louis University, St. Louis, MO Address correspondence to: Dr. Kevin J. Martin, Division of Nephrology, Saint Louis University Medical Center, Division of Nephrology (9-FDT), 3635 Vista Avenue, St. Louis, MO 63110l. Phone: 314-577-8765; Fax: 314-771-0784; martinkj@slu.edu Metabolic bone disease is a common complication of chronic kidney disease (CKD) and is part of a broad spectrum of disorders of mineral metabolism that occur in this clinical setting and result in both skeletal and extraskeletal consequences. Detailed research in that past 4 decades has uncovered many of the mechanisms that are involved in the initiation and maintenance of the disturbances of bone and mineral metabolism and has been translated successfully from "bench to bedside" so that efficient therapeutic strategies now are available to control the complications of disturbed mineral metabolism. Recent emphasis is on the need to begin therapy early in the course of CKD. Central to the assessment of disturbances in bone and mineral metabolism is the ability to make an accurate assessment of the bone disease by noninvasive means. This remains somewhat problematic, and although measurements of parathyroid hormone are essential, recently recognized difficulties with these assays make it difficult to provide precise clinical practice guidelines for the various stages of CKD at the present time. Further research and progress in this area continue to evaluate the appropriate interventions to integrate therapies for both the skeletal and extraskeletal consequences with a view toward improving patient outcomes. |
回复此楼» 猜你喜欢
求助各位大神，谢谢
已经有2人回复
-
NSFC已审核
已经有109人回复
-
消化系统论文润色/翻译怎么收费?
已经有203人回复
-
散金祈福
已经有272人回复
-
求助各位大佬
已经有2人回复
-
刚查时间戳
已经有16人回复
-
德国科隆大学医学中心Prof. Vogt 研究组招聘CSC公派博士生。
已经有0人回复